INFORMATION FOR
News
Congratulations to the following Yale Department of Internal Medicine faculty members, who were recently promoted, appointed, or reappointed.
In an interview, Rachel Perry, PhD, discusses the link between insulin and cancer, a surprising finding in her research, and the future of precision medicine for metabolism-related cancers.
Dr. Rachel Perry on Yale Cancer Answers.
This inaugural event marked the launch of the Cancer Metabolism Initiative (CAMI), which aims to bring together investigators from across the campus to shape the future of cancer metabolism.
The research team found that a metabolism-targeting drug called dichloroacetate (DCA) helped alleviate CRF in mice, without interfering with cancer treatments.
Millions of patients die each year from critical illnesses that involve sepsis, which is a condition that disrupts the normal balance of body systems due to an infection and is associated with high inflammation.
Two PhD students in the Graduate School of Arts and Sciences have been selected as recipients of the esteemed Howard Hughes Medical Institute (HHMI) Gilliam Fellowships. This distinction recognizes exceptional achievements in scientific research and acknowledges student potential as future leaders in their respective fields. The Graduate School is proud to announce that Ngozi Akingbesote and April Pruitt have been awarded the highly competitive HHMI Gilliam Fellowships. These talented individuals have demonstrated unwavering dedication, ingenuity, and innovation in their respective areas of study, making substantial contributions to the scientific community.
Rachel Perry, PhD, assistant professor of medicine (endocrinology) and of cellular and molecular physiology, received the Endocrinology and Metabolism Section New Investigator Award from the American Physiological Society (APS) during its summit on April 21.
Discoveries & Impact highlights select scientific discoveries across the Department of Internal Medicine...
Yale Cancer Center’s Annual Conclave was held on January 5, 2023 to recognize scientific and clinical accomplishments of the Center's faculty and staff in 2022. Dr. Eric Winer hosted the event and presented research awards in four categories.
Scientists at Yale Cancer Center have found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the effectiveness of subsequent chemotherapy treatments. The findings were published today in Communications Biology.
Rachel Perry, PhD, received the R01 grant. Drs. Andrew Wang and Adebowale Adeniran are co-investigators.
In 2022, Lion Heart, a foundation dedicated to supporting breast cancer research at Yale, will celebrate awarding its 10th series of breast cancer research grants to support Yale Cancer Center and Smilow Cancer Hospital.
AnnMarie Liapakis to be Honored as a Transplantation "Superhero"; Xavier Llor and Erin Hofstatter co-edit new book; Rachel Perry To Give Keynote Address; YIMA Recognized
Discoveries & Impact (February 2021)
Discoveries & Impact (December 2020)
New Study Identifies Ways to Restore the Hormonal Balance Disturbed in Metabolic Disease
Now Yale scientists report March 4 in the journal Nature that they have discovered the molecular mechanisms that trigger metabolic imbalance between these two distinct but linked processes, a finding with implications for the treatment of diabetes and non-alcoholic fatty liver disease (NAFLD).
Nearly 40 percent of Americans over the age of 20 are obese, and another 32 percent are overweight. These alarming figures grow darker when combined with statistics showing that obesity is second only to smoking as a cause of preventable cancer deaths. Obesity has been linked to more than a dozen types of cancer.
Cellular & Molecular Physiology 2019 Annual Retreat